Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.100
-0.080 (-2.52%)
At close: Apr 2, 2025, 4:00 PM
3.141
+0.041 (1.32%)
After-hours: Apr 2, 2025, 7:47 PM EDT

Alterity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Market Capitalization
341411224412
Upgrade
Market Cap Growth
96.98%23.14%-47.27%-50.72%259.32%-30.44%
Upgrade
Enterprise Value
316-5-4174
Upgrade
Last Close Price
3.101.812.796.1113.0011.90
Upgrade
PS Ratio
14.555.224.366.1113.45-
Upgrade
PB Ratio
6.961.520.750.881.922.47
Upgrade
P/TBV Ratio
5.471.520.750.881.922.47
Upgrade
EV/Sales Ratio
13.342.22--5.37-
Upgrade
Debt / Equity Ratio
0.010.010.010.000.000.01
Upgrade
Asset Turnover
0.230.170.110.140.20-
Upgrade
Quick Ratio
3.763.105.586.7910.563.41
Upgrade
Current Ratio
3.843.546.177.0710.923.62
Upgrade
Return on Equity (ROE)
-155.77%-104.47%-47.38%-38.97%-81.39%-113.53%
Upgrade
Return on Assets (ROA)
-78.37%-52.66%-26.64%-25.85%-43.62%-58.39%
Upgrade
Return on Capital (ROIC)
-99.57%-66.27%-31.21%-29.30%-50.30%-73.35%
Upgrade
Earnings Yield
-36.51%-91.15%-80.84%-41.06%-26.24%-76.31%
Upgrade
FCF Yield
-30.92%-60.11%-117.35%-39.72%-29.72%-53.57%
Upgrade
Buyback Yield / Dilution
-104.33%-50.29%-0.91%-41.79%-89.62%-45.32%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q